MAPEMA is a pharmacy in Lanaken. Public Limited, started on 5 June 2000, 1 establishment.

What is the address of MAPEMA?

The registered office of MAPEMA is located at Groenstraat 3, 3621 Lanaken.

Is MAPEMA still active?

Yes. According to the CBE (29 October 2026) MAPEMA is active, legal situation “Normale toestand”, started on 5 June 2000.

Is MAPEMA registered on Peppol?

Yes, MAPEMA is registered on the Peppol network with ID 0208:0472045946.

What is the enterprise number of MAPEMA?

The enterprise number of MAPEMA is BE0472045946.

When was MAPEMA founded?

MAPEMA was founded on 5 June 2000.

Is MAPEMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 June 2000; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MAPEMA make in 2025?

MAPEMA posted a profit after taxes of € 9,230 in financial year 2025.

What is the revenue of MAPEMA?

As a small company, MAPEMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 747,511.

MAPEMA (Public Limited) - Lanaken - BE0472045946

Dossier MAPEMA, printed on 29 October 2026 from databakkes.be/en/0472045946/mapema. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 23 % of short-term debt in 2025; threshold 65 %.
Figures corrected NBB

Corrected annual account filed for 2023.

Financials

Financial year 2025

MAPEMA from Lanaken, company number BE0472045946, closed financial year 2025 with a result of € 9,230 after tax. For that financial year MAPEMA recorded a gross margin of € 747,511 and equity of € 154,143. Compared with financial year 2024, the result moved from € 799 to € 9,230. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 28, 2026.

What it is worth Growing

€ 154,143

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 9,230

▲ € 8,431 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 120,524

▲ € 119,322 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 35,551.

People and assets in 2025

Wage cost

€ 203,196

▲ 51% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 10,618

▲ 78% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 16 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 5 million

▲ 2% vs 2024

€ 317,535 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.

Owed to suppliers

€ 103,354

▲ € 93,721 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 45,453

▲ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 200,016 Gross margin 2022: € 200,016 First fiscal year in the series	€ 791,301 Gross margin 2023: € 791,301 ▲ 296% vs 2022 (€ 200,016) Favourable step	€ 572,877 Gross margin 2024: € 572,877 ▼ 28% vs 2023 (€ 791,301) Unfavourable step	€ 747,511 Gross margin 2025: € 747,511 ▲ 30% vs 2024 (€ 572,877) Favourable step	▲ 30%
Profit after taxes	€ -108,482 Profit after taxes 2022: € -108,482 First fiscal year in the series	€ 339,080 Profit after taxes 2023: € 339,080 ▲ € 447,562 vs 2022 (€ -108,482) Favourable step	€ 799 Profit after taxes 2024: € 799 ▼ € 338,281 vs 2023 (€ 339,080) Unfavourable step	€ 9,230 Profit after taxes 2025: € 9,230 ▲ € 8,431 vs 2024 (€ 799) Favourable step	▲ € 8,431
Equity	€ -194,965 Equity 2022: € -194,965 First fiscal year in the series	€ 144,115 Equity 2023: € 144,115 ▲ € 339,080 vs 2022 (€ -194,965) Favourable step	€ 144,914 Equity 2024: € 144,914 ▲ 1% vs 2023 (€ 144,115) Favourable step	€ 154,143 Equity 2025: € 154,143 ▲ 6% vs 2024 (€ 144,914) Favourable step	▲ 6%
Total debts	€ 3,262,383 Total debts 2022: € 3,262,383 First fiscal year in the series	€ 4,702,112 Total debts 2023: € 4,702,112 ▲ 44% vs 2022 (€ 3,262,383) Unfavourable step	€ 5,746,164 Total debts 2024: € 5,746,164 ▲ 22% vs 2023 (€ 4,702,112) Unfavourable step	€ 6,101,448 Total debts 2025: € 6,101,448 ▲ 6% vs 2024 (€ 5,746,164) Unfavourable step	▲ 6%
Cash	€ 5,246 Cash 2022: € 5,246 First fiscal year in the series	€ 2,115 Cash 2023: € 2,115 ▼ 60% vs 2022 (€ 5,246) Unfavourable step	€ 1,202 Cash 2024: € 1,202 ▼ 43% vs 2023 (€ 2,115) Unfavourable step	€ 120,524 Cash 2025: € 120,524 ▲ € 119,322 vs 2024 (€ 1,202) Favourable step	▲ € 119,322
Land & buildings	€ 2,651,066 Land & buildings 2022: € 2,651,066 First fiscal year in the series	€ 3,908,950 Land & buildings 2023: € 3,908,950 ▲ 47% vs 2022 (€ 2,651,066) Unchanged	€ 5,058,704 Land & buildings 2024: € 5,058,704 ▲ 29% vs 2023 (€ 3,908,950) Unchanged	€ 5,338,146 Land & buildings 2025: € 5,338,146 ▲ 6% vs 2024 (€ 5,058,704) Unchanged	▲ 6%
Retained profit	€ -313,557 Retained profit 2022: € -313,557 First fiscal year in the series	€ 25,523 Retained profit 2023: € 25,523 ▲ € 339,080 vs 2022 (€ -313,557) Favourable step	€ 26,322 Retained profit 2024: € 26,322 ▲ 3% vs 2023 (€ 25,523) Favourable step	€ 35,551 Retained profit 2025: € 35,551 ▲ 35% vs 2024 (€ 26,322) Favourable step	▲ 35%
Bank debt	€ 2,378,906 Bank debt 2022: € 2,378,906 First fiscal year in the series	€ 4,038,470 Bank debt 2023: € 4,038,470 ▲ 70% vs 2022 (€ 2,378,906) Unfavourable step	€ 4,899,896 Bank debt 2024: € 4,899,896 ▲ 21% vs 2023 (€ 4,038,470) Unfavourable step	€ 4,976,553 Bank debt 2025: € 4,976,553 ▲ 2% vs 2024 (€ 4,899,896) Unfavourable step	▲ 2%
Balance sheet total	€ 3,067,418 Balance sheet total 2022: € 3,067,418 First fiscal year in the series	€ 4,846,227 Balance sheet total 2023: € 4,846,227 ▲ 58% vs 2022 (€ 3,067,418) Unchanged	€ 5,891,077 Balance sheet total 2024: € 5,891,077 ▲ 22% vs 2023 (€ 4,846,227) Unchanged	€ 6,255,591 Balance sheet total 2025: € 6,255,591 ▲ 6% vs 2024 (€ 5,891,077) Unchanged	▲ 6%

Key figures of MAPEMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MAPEMA?

What happened at MAPEMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 28, 2026 New annual accounts for financial year 2025: profit of € 9,230 (▲ € 8,431 vs 2024). filed late Source: NBB ↗
Jul 6, 2000 New establishment in Estaimpuis. KBO
Jun 5, 2000 Start of the company according to the CBE. KBO

In short

From € 108,482 loss in 2022 to € 9,230 profit in 2025.

Paid € 17,682 in corporate taxes since 2022.

Best year ever: 2023, with € 339,080 profit.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Groenstraat 3

3621 Lanaken

2.093.909.702

Rue de Warlengrie(EST) 18

7730 Estaimpuis

Active since 6 July 2000

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0472.045.946

VAT number

BE 0472.045.946

Registered office

Groenstraat 3, 3621 Lanaken

Names & denominations

MAPEMA

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

5 June 2000

Peppol

Active · Active since 19 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Groothandel in farmaceutische producten

Adviesbureaus op het gebied van public relations en communicatie

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Groothandel in farmaceutische en medische artikelen

Vervaardiging van geneesmiddelen

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗